BCR and pachyonychia congenita: In summary, we have trained, tested, and validated a novel 3-miRNA prognostic classifier (miR-185-5p+miR-221-3p+miR-326) that predicted time to BCR after RP independently of routine clinicopathological parameters in three independent PC patient cohorts.